Menu
Live News EQUITY H impact

ABBV Acquires APGE

AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio

ABBVAPGE

ABBV APGE - AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio